| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.60B | 21.32B | 19.84B | 17.68B | 15.99B | 14.14B |
| Gross Profit | 7.76B | 7.71B | 7.08B | 5.86B | 4.96B | 4.47B |
| EBITDA | 4.25B | 4.17B | 3.86B | 3.15B | 2.72B | 2.32B |
| Net Income | 2.90B | 2.92B | 2.57B | 2.02B | 1.76B | 1.42B |
Balance Sheet | ||||||
| Total Assets | 22.75B | 21.42B | 20.15B | 19.39B | 18.08B | 18.06B |
| Cash, Cash Equivalents and Short-Term Investments | 1.07B | 1.76B | 1.59B | 1.10B | 1.22B | 2.16B |
| Total Debt | 4.62B | 4.62B | 5.38B | 4.78B | 4.84B | 4.84B |
| Total Liabilities | 14.14B | 12.82B | 12.66B | 12.37B | 11.98B | 11.79B |
| Stockholders Equity | 8.61B | 8.60B | 7.46B | 7.00B | 6.11B | 6.27B |
Cash Flow | ||||||
| Free Cash Flow | 3.16B | 2.81B | 2.77B | 2.09B | 1.21B | 1.37B |
| Operating Cash Flow | 3.50B | 3.19B | 3.15B | 2.39B | 1.50B | 1.59B |
| Investing Cash Flow | -1.01B | -640.00M | -562.90M | -1.17B | -540.40M | -545.70M |
| Financing Cash Flow | -2.31B | -2.50B | -2.02B | -1.35B | -1.85B | -2.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $99.85B | 39.77 | 34.71% | 0.95% | 6.36% | 7.42% | |
72 Outperform | $84.04B | 32.41 | 25.46% | 1.27% | -0.60% | 49.11% | |
71 Outperform | $17.17B | 34.45 | 72.05% | 0.96% | -2.03% | -1.09% | |
69 Neutral | $52.82B | 49.39 | 9.34% | 1.65% | -5.07% | -65.16% | |
67 Neutral | $10.96B | 42.48 | 13.40% | 0.53% | 28.27% | -25.82% | |
66 Neutral | $13.31B | 26.65 | 38.36% | 1.28% | -0.53% | -1.29% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |